Correlation Between Privi Speciality and Sakar Healthcare

Can any of the company-specific risk be diversified away by investing in both Privi Speciality and Sakar Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Privi Speciality and Sakar Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Privi Speciality Chemicals and Sakar Healthcare Limited, you can compare the effects of market volatilities on Privi Speciality and Sakar Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Privi Speciality with a short position of Sakar Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Privi Speciality and Sakar Healthcare.

Diversification Opportunities for Privi Speciality and Sakar Healthcare

0.3

Correlation Coefficient

Privi Speciality  Sakar Healthcare

Weak diversification

The 3 months correlation between Privi and Sakar is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Privi Speciality Chemicals and Sakar Healthcare Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sakar Healthcare and Privi Speciality is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Privi Speciality Chemicals are associated (or correlated) with Sakar Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sakar Healthcare has no effect on the direction of Privi Speciality i.e., Privi Speciality and Sakar Healthcare go up and down completely randomly.

Pair Corralation between Privi Speciality and Sakar Healthcare

Assuming the 90 days trading horizon Privi Speciality Chemicals is expected to generate 0.93 times more return on investment than Sakar Healthcare. However, Privi Speciality Chemicals is 1.07 times less risky than Sakar Healthcare. It trades about 0.14 of its potential returns per unit of risk. Sakar Healthcare Limited is currently generating about -0.03 per unit of risk. If you would invest  158,790  in Privi Speciality Chemicals on October 10, 2024 and sell it today you would earn a total of  28,505  from holding Privi Speciality Chemicals or generate 17.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Privi Speciality Chemicals  vs.  Sakar Healthcare Limited

Privi Speciality Che

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Privi Speciality Chemicals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Privi Speciality exhibited solid returns over the last few months and may actually be approaching a breakup point.

Sakar Healthcare

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sakar Healthcare Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward-looking signals, Sakar Healthcare is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Privi Speciality and Sakar Healthcare

The main advantage of trading using opposite Privi Speciality and Sakar Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Privi Speciality position performs unexpectedly, Sakar Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sakar Healthcare will offset losses from the drop in Sakar Healthcare's long position.

The idea behind Privi Speciality Chemicals and Sakar Healthcare Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.